Drugs Made In Stock Technical Analysis
| DMAA Stock | 10.43 0.01 0.1% |
As of the 5th of February, Drugs Made shows the Coefficient Of Variation of 589.8, standard deviation of 0.1123, and Mean Deviation of 0.0786. Drugs Made In technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Drugs Made Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Drugs, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DrugsDrugs Made's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Drugs Made assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Drugs Made's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Drugs Made 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drugs Made's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drugs Made.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Drugs Made on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Drugs Made In or generate 0.0% return on investment in Drugs Made over 90 days. Drugs Made is related to or competes with SIM Acquisition, Mountain Lake, Centurion Acquisition, Berto Acquisition, Titan Acquisition, Oyster Enterprises, and Renatus Tactical. More
Drugs Made Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drugs Made's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drugs Made In upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1745 | |||
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 0.5781 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1936 |
Drugs Made Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drugs Made's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drugs Made's standard deviation. In reality, there are many statistical measures that can use Drugs Made historical prices to predict the future Drugs Made's volatility.| Risk Adjusted Performance | 0.0705 | |||
| Jensen Alpha | 0.0086 | |||
| Total Risk Alpha | 0.0038 | |||
| Sortino Ratio | (0.15) | |||
| Treynor Ratio | 0.779 |
Drugs Made February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0705 | |||
| Market Risk Adjusted Performance | 0.789 | |||
| Mean Deviation | 0.0786 | |||
| Downside Deviation | 0.1745 | |||
| Coefficient Of Variation | 589.8 | |||
| Standard Deviation | 0.1123 | |||
| Variance | 0.0126 | |||
| Information Ratio | (0.23) | |||
| Jensen Alpha | 0.0086 | |||
| Total Risk Alpha | 0.0038 | |||
| Sortino Ratio | (0.15) | |||
| Treynor Ratio | 0.779 | |||
| Maximum Drawdown | 0.5781 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1936 | |||
| Downside Variance | 0.0304 | |||
| Semi Variance | (0.01) | |||
| Expected Short fall | (0.13) | |||
| Skewness | (0.13) | |||
| Kurtosis | 1.62 |
Drugs Made In Backtested Returns
At this point, Drugs Made is very steady. Drugs Made In secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Drugs Made In, which you can use to evaluate the volatility of the firm. Please confirm Drugs Made's Standard Deviation of 0.1123, mean deviation of 0.0786, and Coefficient Of Variation of 589.8 to check if the risk estimate we provide is consistent with the expected return of 0.019%. Drugs Made has a performance score of 13 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0116, which means not very significant fluctuations relative to the market. As returns on the market increase, Drugs Made's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drugs Made is expected to be smaller as well. Drugs Made In right now shows a risk of 0.11%. Please confirm Drugs Made In downside variance, kurtosis, and the relationship between the value at risk and expected short fall , to decide if Drugs Made In will be following its price patterns.
Auto-correlation | 0.80 |
Very good predictability
Drugs Made In has very good predictability. Overlapping area represents the amount of predictability between Drugs Made time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drugs Made In price movement. The serial correlation of 0.8 indicates that around 80.0% of current Drugs Made price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Drugs Made In Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Drugs Made In volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Drugs Made Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Drugs Made In on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Drugs Made In based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Drugs Made In price pattern first instead of the macroeconomic environment surrounding Drugs Made In. By analyzing Drugs Made's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Drugs Made's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Drugs Made specific price patterns or momentum indicators. Please read more on our technical analysis page.
Drugs Made February 5, 2026 Technical Indicators
Most technical analysis of Drugs help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Drugs from various momentum indicators to cycle indicators. When you analyze Drugs charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0705 | |||
| Market Risk Adjusted Performance | 0.789 | |||
| Mean Deviation | 0.0786 | |||
| Downside Deviation | 0.1745 | |||
| Coefficient Of Variation | 589.8 | |||
| Standard Deviation | 0.1123 | |||
| Variance | 0.0126 | |||
| Information Ratio | (0.23) | |||
| Jensen Alpha | 0.0086 | |||
| Total Risk Alpha | 0.0038 | |||
| Sortino Ratio | (0.15) | |||
| Treynor Ratio | 0.779 | |||
| Maximum Drawdown | 0.5781 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1936 | |||
| Downside Variance | 0.0304 | |||
| Semi Variance | (0.01) | |||
| Expected Short fall | (0.13) | |||
| Skewness | (0.13) | |||
| Kurtosis | 1.62 |
Drugs Made February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Drugs stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 4.60 | ||
| Daily Balance Of Power | 0.50 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 10.44 | ||
| Day Typical Price | 10.44 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |